Isoalantolactone protects against Staphylococcus aureus pneumonia.

Jiazhang Qiu,Mingjing Luo,Jianfeng Wang,Jing Dong,Hongen Li,Bingfeng Leng,Qian Zhang,Xiaohan Dai,Yu Zhang,Xiaodi Niu,Xuming Deng
DOI: https://doi.org/10.1111/j.1574-6968.2011.02397.x
2011-01-01
FEMS Microbiology Letters
Abstract:Staphylococcus aureus is a versatile pathogen that can cause life-threatening infections. The growing emergence of methicillin-resistant S. aureus strains and a decrease in the discovery of new antibiotics warrant the search for new therapeutic targets to combat infections. Staphylococcus aureus produces many extracellular virulence factors that contribute to its pathogenicity. Therefore, targeting bacterial virulence as an alternative strategy to the development of new antimicrobials has gained great interest. alpha-Toxin is a 33.2-kDa, water-soluble, pore-forming toxin that is secreted by most S. aureus strains. alpha-Toxin is essential for the pathogenesis of pneumonia, as strains lacking alpha-toxin display a profound defect in virulence. In this report, we demonstrate that isoalantolactone (IAL), a naturally occurring compound found in Inula helenium (Compositae), has no anti-S. aureus activity as per MIC evaluation in vitro. However, IAL can markedly inhibit the expression of a-toxin in S. aureus at very low concentrations. Furthermore, the in vivo data indicate that treatment with IAL protects mice from S. aureus pneumonia.
What problem does this paper attempt to address?